ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,594Medicare Part D Prescriptions Filled, Including Refills

Rank: 38 out of 113

$382K Total Retail Price of All Prescriptions

Rank: 54 out of 113

361 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 361 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 361 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 7,511 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
SIMVASTATIN 513 474 1 2
LEVOTHYROXINE SODIUM 502 436 2 1
AMLODIPINE BESYLATE 335 300 3 4
HYDROCODONE-ACETAMINOPHEN 311 236 S3 4 7
OMEPRAZOLE 262 249 5 5
FUROSEMIDE 241 203 6 6
LOSARTAN POTASSIUM 206 192 7 13
METFORMIN HCL 186 174 8 11
ATORVASTATIN CALCIUM 174 168 9 15
CITALOPRAM HBR 168 122 10 17
HYDROCHLOROTHIAZIDE 147 139 11 9
POTASSIUM CHLORIDE 136 132 12 12
ZOLPIDEM TARTRATE 133 107 13 19
METOPROLOL TARTRATE 125 112 14 14
WARFARIN SODIUM 117 116 15 8
ALLOPURINOL 115 113 16 20
METOPROLOL SUCCINATE 108 103 17 10
TRIAMTERENE-HCTZ 104 101 18 26
ATENOLOL 98 74 19 16
FENTANYL 94 54 S2 20 43
BENAZEPRIL HCL 94 86 20 46
LISINOPRIL 92 81 22 3
CRESTOR 92 92 22 30
GABAPENTIN 82 61 24 18
SERTRALINE HCL 78 63 25 21
ALENDRONATE SODIUM 77 74 26 22
ESCITALOPRAM OXALATE 76 76 27 86
LOSARTAN-HYDROCHLOROTHIAZIDE 75 75 28 40
TRAMADOL HCL 75 71 28 29
ENALAPRIL MALEATE 69 69 30 50
PRAVASTATIN SODIUM 64 64 31 23
OXYCODONE HCL 63 52 S2 32 62
VENLAFAXINE HCL ER 63 38 32 55
NEXIUM 63 34 32 47
TAMSULOSIN HCL 57 57 35 24
GLIPIZIDE 55 55 36 75
CARVEDILOL 55 52 36 25
FOSINOPRIL SODIUM 54 50 38 138
PREDNISONE 54 41 38 28
GEMFIBROZIL 53 49 40 61
FLUOXETINE HCL 52 52 41 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.